Newer indications for permanent pacemakers.
The role of pacemakers in cardiac disease continues to expand, and recent technology has allowed therapy to be individualized. Newer indications for pacemakers now include long QT syndrome, neurocardiogenic syncope, hypertrophic obstructive cardiomyopathy, and drug refractory atrial fibrillation.
Rosero
S Z
SZ
University of Rochester Medical Center, NY 14642, USA.
Akiyama
T
T
D000328:Adult; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D002648:Child; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced / Q000151:congenital / Q000628:therapy*; D008297:Male; D010138:Pacemaker, Artificial; D019462:Syncope, Vasovagal / Q000628:therapy*; D013617:Tachycardia, Supraventricular / Q000628:therapy*